Programmed cell death in alcohol-associated liver disease

95Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Alcohol-associated liver disease (ALD), which ranges from mild disease to alcohol-associated hepatitis and cirrhosis, is the most prevalent type of chronic liver disease and a leading cause of morbidity and mortality worldwide. Accumulating evidence reveals that programmed cell death (PCD) plays a crucial role in progression of ALD involving crosstalk between hepatocytes and immune cells. Multiple pathways of PCD, including apoptosis, necroptosis, autophagy, pyroptosis and ferroptosis, are reported in ALD. Interestingly, PCD pathways are intimately linked and interdependent, making it difficult to therapeutically target a single pathway. This review clarifies the multiple types of PCD occurring in liver and focuses on crosstalk between hepatocytes and innate immune cells in ALD.

Cite

CITATION STYLE

APA

Miyata, T., & Nagy, L. E. (2020, October 1). Programmed cell death in alcohol-associated liver disease. Clinical and Molecular Hepatology. Korean Association for the Study of the Liver. https://doi.org/10.3350/cmh.2020.0142

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free